Levamisole

Levamisole Recall Summary Levamisole, an active pharmaceutical ingredient, has been recalled across the European Union due to adverse events. This is a Class II recall, meaning the product could cause temporary adverse health effects or poses only a slight threat of serious adverse health consequences. The recall affects levamisole-containing medications distributed throughout EU member states.

Product
Active substances: levamisole
Reason
Adverse event
Classification
Class II
Category
drug recall
Country
European Union
Agency
EMA-DHPC
Recall date
2026-04-16
Status
Ongoing
Distribution
European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/efe96310-eafc-4b55-91f7-7733cd6c4308